Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features | CURRENT PROBLEMS IN CANCER |